These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37589914)

  • 21. PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis.
    Burza MA; Molinaro A; Attilia ML; Rotondo C; Attilia F; Ceccanti M; Ferri F; Maldarelli F; Maffongelli A; De Santis A; Attili AF; Romeo S; Ginanni Corradini S
    Liver Int; 2014 Apr; 34(4):514-20. PubMed ID: 24102786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PNPLA3 risk allele is associated with risk of hepatocellular carcinoma but not decompensation in compensated cirrhosis.
    Urias E; Tedesco NR; Burkholder DA; Moran IJ; Miller MJ; Jasty VSJ; Patil S; Zoellner S; Wijarnpreecha K; Chen VL
    Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38780253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationships between Genetic Variations of PNPLA3, TM6SF2 and Histological Features of Nonalcoholic Fatty Liver Disease in Japan.
    Akuta N; Kawamura Y; Arase Y; Suzuki F; Sezaki H; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Suzuki Y; Ikeda K; Kumada H
    Gut Liver; 2016 May; 10(3):437-45. PubMed ID: 26610348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PNPLA3 and TM6SF2 genetic variants and hepatic fibrosis and cirrhosis in Pakistani chronic hepatitis C patients: a genetic association study.
    Rauff B; Alzahrani B; Chudhary SA; Nasir B; Mahmood S; Bhinder MA; Faheem M; Amar A
    BMC Gastroenterol; 2022 Aug; 22(1):401. PubMed ID: 36028802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of CXCL9-11 gene polymorphisms in liver fibrosis among patients with chronic hepatitis C.
    Magri MC; Alvarez MSM; Iogi AA; Alves GM; Manchiero C; Dantas BP; Prata TVG; Nunes AKDS; Tengan FM
    Pathog Dis; 2021 Mar; 79(3):. PubMed ID: 33476381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. African genetic ancestry is associated with lower frequency of PNPLA3 G allele in non-alcoholic fatty liver in an admixed population.
    Cavalcante LN; Porto J; Mazo D; Longatto-Filho A; Stefano JT; Lyra AC; Carrilho FJ; Reis RM; Alves VAF; Sanyal AJ; Oliveira CP
    Ann Hepatol; 2022; 27(6):100728. PubMed ID: 35710086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of Type 2 Diabetes in the Association of
    Gabriel-Medina P; Ferrer-Costa R; Rodriguez-Frias F; Ciudin A; Augustin S; Rivera-Esteban J; Pericàs JM; Selva DM
    Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of Caloric Intake Might Override the Prosteatotic Effects of the PNPLA3 p.I148M and TM6SF2 p.E167K Variants in Patients with Fatty Liver: Ultrasound-Based Prospective Study.
    Krawczyk M; Stachowska E; Milkiewicz P; Lammert F; Milkiewicz M
    Digestion; 2016; 93(2):139-48. PubMed ID: 26745555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic disorders induced by PNPLA3 and TM6SF2 gene variants affect chronic kidney disease in patients infected with non-genotype 3 hepatitis C virus.
    Liu J; Qi W; Wang S; Zhang Y; Wang X; Sun D; Xu Y; Shi J; Duan H; Zhang Q; Wang H; Wang J
    Lipids Health Dis; 2023 Jul; 22(1):91. PubMed ID: 37400794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption.
    Mancina RM; Ferri F; Farcomeni A; Molinaro A; Maffongelli A; Mischitelli M; Poli E; Parlati L; Burza MA; De Santis A; Attilia F; Rotondo C; Rando MM; Attilia ML; Ceccanti M; Ginanni Corradini S
    Appl Clin Genet; 2019; 12():1-10. PubMed ID: 30666147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity.
    Sookoian S; Castaño GO; Scian R; Mallardi P; Fernández Gianotti T; Burgueño AL; San Martino J; Pirola CJ
    Hepatology; 2015 Feb; 61(2):515-25. PubMed ID: 25302781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models.
    Longo M; Meroni M; Paolini E; Erconi V; Carli F; Fortunato F; Ronchi D; Piciotti R; Sabatini S; Macchi C; Alisi A; Miele L; Soardo G; Comi GP; Valenti L; Ruscica M; Fracanzani AL; Gastaldelli A; Dongiovanni P
    Cell Mol Gastroenterol Hepatol; 2022; 13(3):759-788. PubMed ID: 34823063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic Determinants of Circulating Lipoproteins in Nonalcoholic Fatty Liver Disease.
    Jiang ZG; Tapper EB; Kim M; Connelly MA; Krawczyk SA; Yee EU; Herman MA; Mukamal KJ; Lai M
    J Clin Gastroenterol; 2018; 52(5):444-451. PubMed ID: 28362682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of PNPLA3 and TM6SF2 polymorphisms on the prognosis of patients with MASLD and type 2 diabetes mellitus.
    Lavrado NC; Salles GF; Cardoso CRL; de França PHC; Melo MFDGG; Leite NC; Villela-Nogueira CA
    Liver Int; 2024 Apr; 44(4):1042-1050. PubMed ID: 38293718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-nucleotide rs738409 polymorphisms in the PNPLA3 gene are strongly associated with alcoholic liver disease in Han Chinese males.
    Zhang Y; Guo T; Yang F; Mao Y; Li L; Liu C; Sun Q; Li Y; Huang J
    Hepatol Int; 2018 Sep; 12(5):429-437. PubMed ID: 30132178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of TM6SF2 E167K and PNPLA3 I148M variants in NAFLD in northeast China.
    Xu M; Li Y; Zhang S; Wang X; Shen J; Zhang S
    Ann Hepatol; 2019; 18(3):456-460. PubMed ID: 31054977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Membrane-bound O-Acyltransferase7 rs641738 Variant in Pediatric Nonalcoholic Fatty Liver Disease.
    Di Sessa A; Umano GR; Cirillo G; Del Prete A; Iacomino R; Marzuillo P; Del Giudice EM
    J Pediatr Gastroenterol Nutr; 2018 Jul; 67(1):69-74. PubMed ID: 29601441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis.
    Nischalke HD; Berger C; Luda C; Berg T; Müller T; Grünhage F; Lammert F; Coenen M; Krämer B; Körner C; Vidovic N; Oldenburg J; Nattermann J; Sauerbruch T; Spengler U
    PLoS One; 2011; 6(11):e27087. PubMed ID: 22087248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic variants associated with metabolic dysfunction-associated fatty liver disease in western China.
    Liao S; An K; Liu Z; He H; An Z; Su Q; Li S
    J Clin Lab Anal; 2022 Sep; 36(9):e24626. PubMed ID: 35881683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of candidate gene variants in modulating the risk and severity of alcoholic hepatitis.
    Beaudoin JJ; Liang T; Tang Q; Banini BA; Shah VH; Sanyal AJ; Chalasani NP; Gawrieh S
    Alcohol Clin Exp Res; 2021 Apr; 45(4):709-719. PubMed ID: 33616244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.